Urologic Cancer, Softcover reprint of the original 1st ed. 1983 A Multidisciplinary Perspective

The Department of Continuing Education of Harvard Medical School and members of the faculty of Harvard Medical School held a multidisciplinary course on the management of patients with urologic cancer in the fall of 1982. This course high­ lighted the multidisciplinary approach to the care of these patients, and outlined the clinical and pathophysiological basis for diagnosis and treatment. The term multidisciplinary was essential to the course in which the disciplines of uro­ logic surgery, medical oncology, and radiation therapy were each appropriately emphasized. Widespread interest in the contents of this course, and the timely and useful nature of much of the information presented there, has encouraged us to publish, in as rapid a manner as possible, new information and highlights of that course. A camera-ready format was used to allow rapid production, and a variety of disparate styles were maintained from chapter to chapter--some in prose, others in outline. Again, our intent was to disseminate information rapidly and accurately, and to that end, we felt that consistency of style was irrelevant.

Section I. Prostate Cancer.- 1 Prostate Cancer — Natural History and Staging.- 2 Surgical Management of Prostate Cancer.- 3 Interstitial Radiation Therapy for Management of Localized Prostate Cancer.- 4 External Beam Irradiation for Carcinoma of Prostate.- 5 Management of Advanced Prostate Cancer.- Section II. Kidney Cancer.- 6 Renal Cell Carcinoma — Diagnostic Workup and Natural History.- 7 Surgical Management of Renal Cell Carcinoma.- 8 The Role of Radiation Therapy in Renal Carcinoma.- 9 Management of Isolated Metastases and Advanced Renal Carcinoma.- 10 Cancers of the Renal Pelvis and Ureter.- Section III. Bladder Cancer.- 11A Wilms’ Tumor — Natural History.- 11B Wilms’ Tumor — Surgical Aspects.- 11C Wilms’ Tumor — Chemotherapy.- 12 Bladder Cancer — Natural History.- 13 Intravesical Chemotherapy for Superficial Bladder Carcinoma.- 14 The Role of Surgery in the Management of Invasive Bladder Cancer.- 15 Radiation Therapy in the Management of Bladder Cancer.- 16 Systemic Chemotherapy in the Management of Bladder Cancer.- 17 Rhabdomyosarcoma of the Bladder and Prostate.- Section IV. Testis Cancer.- 18 Chemotherapy of Testis Cancer.- 19 The Role of Surgery in Early Stage Testis Cancer.- 20 Role of Tumor Reductive Surgery after Chemotherapy for Testis Cancer.- 21 Seminoma.- Section V. Complications and New Diagnostic Techniques in Urologic Cancer.- 22 Assessment of Renal Function I — Antibiotic Nephrotoxicity in the Patient with Urologic Cancer.- 23 Assessment of Renal Function II — Cancer Chemotherapy Induced Nephrotoxicity.- 24 Urologic Complications of Gynecologic Cancers.- 25 Radiation Therapy Complications of the Genitourinary Tract.- Section VI. Epidemiology and Miscellaneous Sites.- 26 New Diagnostic Techniques — Lymphoscintigraphy.- 27 ANew Marker for the Detection of Transitional Cell Carcinoma.- 28 In Vitro Clonogenic Chemosensitivity Assay in Urologic Tumors.- 29 Carcinoma of the Adrenal Cortex.- 30A Carcinoma of the Penis.- 30B Chemotherapy of Penile Cancer.- 31 Epidemiology of Urologic Cancers.- 32 The Expanding Role of Medical Oncology in Genitourinary Cancer.- Contributors.